Prosecution Insights
Last updated: November 20, 2026

Hamza A. Darb, USPTO Patent Examiner

Listed by the USPTO as DARB, HAMZA A.

Tech Center 3700 • Art Units: 1645 3763 3783

This examiner grants 74% of resolved cases

Analysis

DARB, HAMZA A. has resolved 554 cases in Tech Center 3700 and Art Unit 1645. The allowance rate is 74.0%, and the median time to allowance is 1233 days. The interview-lift measure is 30.8%, providing a substantial reason to consider examiner interviews.

The listed companies are Boston Scientific Corporation, Aita Bio Inc., and Becton, Dickinson and Company. The leading firms are Davidson Kappel LLC - AiTA Bio, Secant IP, PLLC, and BIOTECH BEACH LAW PC. Counsel can align technical claim analysis with a prepared interview agenda.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

74.0%
Allow Rate
+4.0% vs TC avg
633
Total Applications
+30.8%
Interview Lift
1233
Avg Prosecution Days
Based on 554 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
17.0%
§102 Novelty
50.6%
§103 Obviousness
25.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17851889 SYSTEM AND METHOD FOR RESISTANCE-DEPENDENT, SELF-REGULATED MEDICAL PENETRATION Final Rejection THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
18283685 PERILESIONAL TREATMENT OF SKIN CONDITIONS Final Rejection Veradermics Incorporated
18818959 PROXIMAL EMBOLIC PROTECTION DEVICE FOR CAROTID STENTING Non-Final OA Boston Scientific Scimed, Inc.
18800676 SYSTEMS AND METHODS FOR CONTROLLING NEEDLE PENETRATION Non-Final OA Boston Scientific Scimed, Inc.
18429685 MICROCATHETER MANIFOLD ADAPTER AND ASSOCIATED SYSTEMS AND METHODS Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18721433 FLUOROSCOPIC IMAGE GUIDED ROBOTIC BLOOD VESSEL CANNULATION Non-Final OA KONINKLIJKE PHILIPS N.V.
18743332 DRUG DELIVERY DEVICE HAVING DAMPING MECHANISM Non-Final OA AMGEN INC.
18720705 AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY Non-Final OA Bayer HealthCare LLC
17955375 HIGH FLEXIBILITY IMPLANT CATHETER WITH LOW COMPRESSION Non-Final OA Edwards Lifesciences Corporation
18514135 ADD-ON WITH ACTUATOR FOR A DRUG DELIVERY DEVICE Final Rejection Ypsomed AG
18611540 SECURE INPUT ON A CONTROL COMPONENT FOR A DIALYSIS MACHINE Non-Final OA Fresenius Medical Care Deutschland GmbH
18902423 INJECTION PEN WITH DIAL BACK AND LAST DOSE CONTROL Non-Final OA Becton, Dickinson and Company
18075220 INTRODUCER NEEDLE HAVING A FLASHBACK NOTCH AND RELATED DEVICES Final Rejection Becton, Dickinson and Company
18310109 DRUG-ELUTING OCULAR IMPLANT Non-Final OA GLAUKOS CORPORATION
18706823 Sub-assembly for a medicament delivery device Final Rejection SHL Medical AG
18045842 DRIVETRAIN FOR ELONGATED MEDICAL DEVICE Final Rejection Corindus, Inc.
18460719 DRUG DELIVERY DEVICE Non-Final OA SENSILE MEDICAL AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Hamza A. Darb's allowance rate?

74.0% of resolved applications examined by Hamza A. Darb were allowed (554 resolved cases), compared with 49.4% across Art Unit 1645 over the last five years.

Does an interview help with examiner Hamza A. Darb?

This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Hamza A. Darb take to allow a patent?

Applications allowed by Hamza A. Darb took 1,233 days on average from filing to allowance.

Which art unit does examiner Hamza A. Darb work in?

Hamza A. Darb examines applications in Art Unit 1645 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month